![Mark Basil Swindells](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mark Basil Swindells
Corporate Officer/Principal at Exscientia AI Ltd.
Network origin in Mark Basil Swindells first degree
Entity | Entity type | Industry | |
---|---|---|---|
Exscientia AI Ltd.
![]() Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom.
12
| Subsidiary | Pharmaceuticals: Generic | 12 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Mark Basil Swindells via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Schering-Plough Corp.
![]() Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Brown University | College/University | Undergraduate Degree | |
OXFORD BIOMEDICA PLC | Biotechnology | Director/Board Member | |
Goldman Sachs & Co. LLC
![]() Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Investment Banks/Brokers | Corporate Officer/Principal Corporate Officer/Principal | |
University of Oxford | College/University | Doctorate Degree Graduate Degree | |
The University of Manchester | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
Oxford Brookes University | College/University | Graduate Degree | |
Barclays Capital, Inc.
![]() Barclays Capital, Inc. Investment Banks/BrokersFinance Barclays Capital, Inc. is a registered broker/dealer headquartered in New York City. The firm was founded in 1997 and is a subsidiary of Barclays Group US, Inc., ultimately owned by Barclays plc (LON: BARC) in Great Britain. Barclays Capital provides large corporate, government and institutional clients a full spectrum of prime brokerage services which includes equities and fixed income financing, OTC Clearing, Futures and Foreign Exchange Prime Brokerage and access to industry insights and analytics from their Strategic Consulting team. | Investment Banks/Brokers | Corporate Officer/Principal | |
University of Cambridge | College/University | Undergraduate Degree | |
McGill University | College/University | Undergraduate Degree | |
The University of Southampton | College/University | Doctorate Degree | |
Organon International, Inc.
![]() Organon International, Inc. Pharmaceuticals: MajorHealth Technology Organon International, Inc. manufactures and markets pharmaceutical products. It develops therapeutics in the fields such as gynecology, fertility, osteoporosis, and anesthesia. The company was founded in 1923 and is located in Roseland, NJ. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
University Of Dundee | College/University | Corporate Officer/Principal | |
Waseda University | College/University | Graduate Degree | |
DBV TECHNOLOGIES | Pharmaceuticals: Major | Public Communications Contact | |
The University of Wales | College/University | Doctorate Degree | |
Nanjing University | College/University | Undergraduate Degree | |
SBVA
![]() SBVA Investment ManagersFinance SBVA (SBVA) is a private equity/venture capital subsidiary of SoftBank Korea Co., Ltd founded in 2000. The firm is headquartered in Seoul, South Korea. | Investment Managers | Private Equity Investor | |
Organon Biosciences, Inc. | Chief Tech/Sci/R&D Officer | ||
Scandia Plastics, Inc. (New Hampshire)
![]() Scandia Plastics, Inc. (New Hampshire) Miscellaneous ManufacturingProducer Manufacturing Scandia Plastics, Inc. manufactures extruded plastic tubes and plastic profiles. Its products include polystyrene (HIPS) tubes and profiles, ABS tubes and profiles, polyethylene (HDPE) tubes and profiles, polypropylene tubes and profiles, other extruded plastics and plastic core tubes. The company was founded in 1971 and is headquartered in Plaistow, NH. | Miscellaneous Manufacturing | Founder | |
ALLERGAN PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Novo Principal Investments
![]() Novo Principal Investments Investment ManagersFinance Novo Principal Investments (Novo Principal) is a private equity operating division of Novo Nordisk Fonden. The firm was established in 1999, and is headquartered in Hellerup, Denmark. | Investment Managers | Private Equity Investor | |
Moelis & Co. (UK) LLP
![]() Moelis & Co. (UK) LLP Investment Banks/BrokersFinance Part of Moelis & Co., Moelis & Co. (UK) LLP is an independent investment bank that provides confidential and unconflicted strategic advice to clients across various industries. The company is based in London, UK. Leveraging their extensive network of 21 geographic locations, the British company delivers the best solutions to their clients. Mark Jonathan Aedy has been the CEO of the company since 2010. | Investment Banks/Brokers | Corporate Officer/Principal | |
Shanghai Yunfeng Investment Management Co. Ltd.
![]() Shanghai Yunfeng Investment Management Co. Ltd. Investment ManagersFinance Shanghai Yunfeng Investment Management Co. Ltd (Yunfeng Capital) is a private equity firm founded in 2010 by Feng Yu and Yun Ma. The firm is headquartered in Shanghai, China. | Investment Managers | Private Equity Investor | |
Science Exchange, Inc.
![]() Science Exchange, Inc. Internet Software/ServicesTechnology Services Science Exchange, Inc. operates an online marketplace for outsourcing science experiments. The firm is a community marketplace for scientists to list, discover access, and pay for scientific services from institutions around the world. The company was founded by Elizabeth Iorns, Ryan Abbott and Daniel John Knox in 2011 and is headquartered in San Francisco, CA. | Internet Software/Services | Director/Board Member | |
UROGEN PHARMA LTD. | Biotechnology | Investor Relations Contact | |
ACTINIUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
ADVERUM BIOTECHNOLOGIES, INC. | Pharmaceuticals: Major | Director/Board Member | |
Harvard Business School | College/University | Masters Business Admin | |
Saïd Business School | College/University | Human Resources Officer | |
Transcelerate Biopharma, Inc.
![]() Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | Biotechnology | Director/Board Member | |
Integrated Clinical Oncology Network Pty Ltd.
![]() Integrated Clinical Oncology Network Pty Ltd. Hospital/Nursing ManagementHealth Services Integrated Clinical Oncology Network Pty Ltd. engages in the provision of cancer and hematological care services. It offers chemotherapy compunding, pharmacy management, remote radiation therapy planning, and medical physics services. The firm also offers patients the option of emerging treatment through clinical trials. The company was founded by Stuart Giles in 2012 and is headquartered in South Brisbane, Australia. | Hospital/Nursing Management | Director/Board Member | |
Pear Therapeutics (US), Inc.
![]() Pear Therapeutics (US), Inc. Packaged SoftwareTechnology Services Pear Therapeutics (US), Inc. develops and provides a platform that combines pharmaceutical preparations with scientifically validated software applications. It offers eFormulation, pharmaceutical-software combination products. The firm combines digital therapies with supplements, medical foods and pharmaceuticals to create more effective treatment solutions. The company was founded in 2013 by Corey M. McCann, Stephen Kennedy Smith and William Greene and is headquartered in Boston. MA. | Packaged Software | Investor Relations Contact | |
Tempus Labs, Inc.
![]() Tempus Labs, Inc. Packaged SoftwareTechnology Services Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL. | Packaged Software | Director/Board Member | |
Mission Bio, Inc.
![]() Mission Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Mission Bio, Inc. engages in the provision of tools for the study of cellular heterogeneity in human health and life science research. It develops research tools that allow high-throughput, single-cell nucleic acid characterization across a variety of research applications, including oncology and immunology. The company was founded by Charlie Silver, Adam Sciambi, Adam Abate, and Dennis Eastburn on June 29, 2011 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Aetion, Inc.
![]() Aetion, Inc. Packaged SoftwareTechnology Services Aetion, Inc. provides data analytics software solutions. The firm?s Aetion Evidence Platform enables life sciences customers to transform disparate data sets into evidence needed to make critical business decisions; and helps payers determine effective treatments for specific patient populations and measure impact in outcomes and utilization. The company was founded by Jeremy A. Rassen, Sebastian Schneeweiss and Allon Rauer in 2013 and is headquartered in New York, NY. | Packaged Software | Director of Finance/CFO | |
Novo Holdings A/S (Investment Company)
![]() Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings A/S (Investment Company) (Novo Holdings-IC) is the investment portfolio division of Novo Holdings A/S, a holding company headquartered in Hellerup, Denmark. They are ultimately owned by Novo Nordisk Fonden (Novo Nordisk Foundation). Founded in 1999, Novo Holdings-IC manages a broad portfolio of the Foundation’s financial assets. | Financial Conglomerates | Director/Board Member | |
Ohana Biosciences, Inc.
![]() Ohana Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Ohana Biosciences, Inc. operates early stage biotechnology firm. The company is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Kinetic Discovery Ltd.
![]() Kinetic Discovery Ltd. Pharmaceuticals: MajorHealth Technology Kinetic Discovery Ltd. engages in the provision of drug discovery services. It offers full kinetic characterization, compound screening, fragment based screening, membrane protein analysis, active concentration determination, epitope mapping, promiscuous binding identification, and consultancy and assay development. The company was founded by Iva Navratilova and Andrew L. Hopkins and is headquartered in Dundee, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer | |
Tarus Therapeutics, Inc.
![]() Tarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Portage Biotech, Inc., Tarus Therapeutics, Inc. is a company developing small molecule inhibitors of adenosine receptors for cancer immunotherapy and select non-oncology indications. The company is based in New York, NY. The company has a comprehensive portfolio of adenosine receptor antagonists in development, including both first-in-class and programs. The company was founded by Sushant Kumar and Peter R. Molloy, with Sushant Kumar serving as CEO since incorporation. Tarus Therapeutics was acquired by Portage Biotech, Inc. on July 05, 2022 for $49.20 million. | Pharmaceuticals: Major | Director/Board Member | |
University of Missouri Extension | College/University | Undergraduate Degree | |
TANGO THERAPEUTICS, INC. | Biotechnology | Public Communications Contact | |
Bayer Crop Science Solutions LLC | Chief Tech/Sci/R&D Officer | ||
EXSCIENTIA PLC | Biotechnology | Chairman Chairman Director of Finance/CFO Investor Relations Contact Founder Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer Public Communications Contact Corporate Officer/Principal General Counsel | |
Mightyowl, Inc. | Director/Board Member | ||
Quanta Dialysis Technologies, Inc. | Director/Board Member | ||
Novo Holdings Equity Us, Inc. | Corporate Officer/Principal |
Statistics
International
United States | 27 |
United Kingdom | 13 |
China | 3 |
Denmark | 3 |
Israel | 2 |
Sectoral
Health Technology | 16 |
Consumer Services | 15 |
Finance | 8 |
Technology Services | 5 |
Commercial Services | 3 |
Operational
Director/Board Member | 35 |
Corporate Officer/Principal | 19 |
Undergraduate Degree | 10 |
Chief Tech/Sci/R&D Officer | 7 |
Founder | 6 |
Most connected contacts
Insiders | |
---|---|
C. Nicholson | 22 |
Elizabeth Crain | 17 |
Robert Ghenchev | 13 |
Joanne Xu | 9 |
Ben Taylor | 7 |
Andrew Hopkins | 7 |
Amanda Galgay | 6 |
Sara Blum Sherman | 4 |
Dave Hallett | 4 |
Garry Pairaudeau | 4 |
Chris Thomas | 4 |
Dan Ireland | 3 |
- Stock Market
- Insiders
- Mark Basil Swindells
- Company connections